ENGLISH TRANSLATION OF JAPANESE-LANGUAGE DOCUMENT
This is a translation of the original Japanese-language document and is provided for convenience only.
In the event of any discrepancy between this translated document and Japanese original, the original shall prevail.

August 1, 2024
To whom it may concern:
Company Name:
Representative:
Inquiries:

TAIYO HOLDINGS CO., LTD.
Eiji Sato, President and CEO(Code: 4626, Listed on Prime
Market of Tokyo Stock Exchange)
Sayaka Tomioka, Managing
Executive Officer, CFO
Tel: +81-3-5953-5200 (main line)

Notice of Revised the First-half and Full-year Earnings Forecasts
for the Fiscal Year Ended March 31, 2025
TAIYO HOLDINGS CO., LTD. hereby announces the revision of the first-half (from April 1, 2024 to September30, 2024) and full-year (from April 1, 2024, to March 31, 2025) consolidated earnings forecasts for the fiscal year
ended March 31, 2025 disclosed on May 1, 2024. The revised forecasts were approved at the Board of Directors
meeting held on August 1, 2024.
1． Revised consolidated earnings forecast for the first-half of the fiscal year ended March 31, 2025 (from April 1,2024 to September 30, 2024)

Net sales

OperatingincomeOrdinary
incomePreviously announced
forecast (A)Millions ofyen
56,100Millions of
yen
9,500

Millions ofyen
9,200Profitattributableto owners ofparent
Millions ofyen
6,200

Revised forecast (B)59,40011,70011,4008,000

Changes (B-A)

3,300

2,200

2,200

1,800

Changes (%)

5.9

23.2

23.9

29.0

51,107

9,089

8,651

6,232

For reference:
Results for the first-half of thefiscal year ended March 31,2024

1Basicearnings pershare
Yen
110.97143.05111.64

ENGLISH TRANSLATION OF JAPANESE-LANGUAGE DOCUMENT
This is a translation of the original Japanese-language document and is provided for convenience only.
In the event of any discrepancy between this translated document and Japanese original, the original shall prevail.

2． Revised consolidated earnings forecast for the fiscal year ended March 31, 2025 (from April 1, 2024 to March 31,2025)

Net sales

OperatingincomeOrdinary
incomePreviously announced
forecast (A)Millions ofyen
112,800

Millions ofyen
18,400Millions ofyen
17,800

Profitattributableto owners ofparent
Millions ofyen
12,000

Revised forecast (B)116,100

20,60020,00013,800Changes (B-A)

3,300

2,200

2,200

1,800

Changes (%)

2.9

12.0

12.4

15.0

104,775

18,203

17,3108,654

For reference:
Results for the fiscal year
ended March 31, 2024

Basicearnings pershareYen
214.77
246.76154.89

3． Reasons for revision
The performance of the Electronics business in the first three months outperformed the forecast due to a weaker
than expected yen and higher than expected demand for white DF Type SR for display materials.
In light of this, we therefore revised the consolidated earnings forecasts, leaving the earnings forecast for the firsthalf onward at the level announced on May 1, 2024 and replacing the Electronics business earnings forecast for thefirst three months with the actual results.
4． Dividend forecast
There has been no change in the dividend forecast announced on May 1, 2024.

2

ENGLISH TRANSLATION OF JAPANESE-LANGUAGE DOCUMENT
This is a translation of the original Japanese-language document and is provided for convenience only.
In the event of any discrepancy between this translated document and Japanese original, the original shall prevail.

For reference:Segment forecasts for net sales and operating income

First-half of the fiscal year ended March 31, 2025

First-half ofthe fiscal year
ended March31, 2024

Previously
announced
forecast (A)Previous fiscalyear results

Segment

Net sales

Operatingincome

Revisedforecast (B)Change(B-A)

Consolidated

56,10059,4003,300

51,107

Electronics

37,70041,0003,300

34,729

Medical andPharmaceuticals

16,00016,000014,609Consolidated

9,500

11,700

2,200

9,089

Electronics

8,800

11,000

2,200

7,702

Medical andPharmaceuticals

1,400

1,400

01,701

Fiscal year
ended March31, 2024

Fiscal year ended March 31, 2025
Segment

Net sales

OperatingincomePreviouslyannounced
forecast (A)Revisedforecast (B)Change (B-A)

Previous fiscal
year results

Consolidated

112,800

116,100

3,300

104,775

Electronics

75,40078,7003,300

71,415

Medical andPharmaceuticals

32,50032,500029,269Consolidated

18,40020,6002,200

18,203

Electronics

17,50019,7002,200

16,456

Medical andPharmaceuticals

2,200

2,200

03,248* The forward-looking statements, including earnings forecasts, contained in these materials are based on information
currently available to the Company and on certain assumptions deemed to be reasonable. The Company makes nopromise regarding achievement of any content in the forward-looking statements. Actual business and other results
may differ substantially due to various factors.

3